Bui TO, Angeli E, El Bouchtaoui M, Gapihan G, Dao VT, Paris J, Leboeuf C, Soussan M, Villarese P, Ziol M, Van Glabeke E, Le TH, Feugeas JP, Janin A, Bousquet G

Exp Hematol Oncol. 2023 05 15;12(1):46

Genomics of Breast Cancer Brain Metastases: A Meta-Analysis and Therapeutic Implications.

Nguyen TT, Hamdan D, Angeli E, Feugeas JP, Le QV, Pamoukdjian F, Bousquet G

Cancers (Basel). 2023 03 12;15(6):

The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer.

Lautré W, Richard E, Feugeas JP, Dumay-Odelot H, Teichmann M

Cancers (Basel). 2022 11 22;14(23):

Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency.

Manceau H, Ausseil J, Masson D, Feugeas JP, Sablonniere B, Guieu R, Puy H, Peoc'h K

Nutrients. 2022 08 5;14(15):

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.

Selmani Z, Molimard C, Overs A, Bazan F, Chaigneau L, Dobi E, Meneveau N, Mansi L, Paillard MJ, Meynard G, Viot J, Algros MP, Borg C, Feugeas JP, Pivot X, Prétet JL, Curtit E

Sci Rep. 2022 Mar 7;12(1):3617

Carence martiale sans anémie : première comorbidité curable de l’insuffisance cardiaque

Peoc'h K, Ausseil J, Feugeas JP, Guieu R, Masson D, Sablonniere B, Puy H

Ann Biol Clin (Paris). 2022 03 1;80(2):109-118

Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.

Bui TO, Dao VT, Nguyen VT, Feugeas JP, Pamoukdjian F, Bousquet G

Eur Urol. 2022 Jan 3;:

GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback.

Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas JP, Perez V, Reynders C, Ancion M, Vigneron M, Baguet A, Guittaut M, Fraichard A, Despouy G

Biology (Basel). 2021 Sep 24;10(10):

Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus.

Nehme Z, Pasquereau S, Haidar Ahmad S, Coaquette A, Molimard C, Monnien F, Algros MP, Adotevi O, Diab Assaf M, Feugeas JP, Herbein G

Oncogene. 2021 Mar 25;:

Botulinum Toxin in WW2 German and Allied Armies: Failures and Myths of Weaponization.

Tatu L, Feugeas JP

Eur Neurol. 2021 Jan 20;:1-8

Autophagy is associated with a robust specific transcriptional signature in breast cancer subtypes.

Grandvallet C, Feugeas JP, Monnien F, Despouy G, Valérie P, Michaël G, Hervouet E, Peixoto P

Genes Cancer. 2020 Dec 31;11(3-4):154-168

EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas.

Lachat C, Bruyère D, Etcheverry A, Aubry M, Mosser J, Warda W, Herfs M, Hendrick E, Ferrand C, Borg C, Delage-Mourroux R, Feugeas JP, Guittaut M, Hervouet E, Peixoto P

Cancers (Basel). 2020 Dec 5;12(12):

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer.

Dao T, Gapihan G, Leboeuf C, Hamdan D, Feugeas JP, Boudabous H, Zelek L, Miquel C, Tran T, Monnot C, Germain S, Janin A, Bousquet G

Oncotarget. 2020 May 5;11(18):1590-1602

Molecular description of ANGPT2 associated colorectal carcinoma.

Jary M, Hasanova R, Vienot A, Asgarov K, Loyon R, Tirole C, Bouard A, Orillard E, Klajer E, Kim S, Viot J, Colle E, Adotevi O, Bouché O, Lecomte T, Borg C, Feugeas JP

Int. J. Cancer. 2020 Mar 29;:

Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes.

Peixoto P, Grandvallet C, Feugeas JP, Guittaut M, Hervouet E

Cells. 2019 Dec 17;8(12):

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target.

Bousquet G, Feugeas JP, Gu Y, Leboeuf C, Bouchtaoui ME, Lu H, Espié M, Janin A, Benedetto MD

Oncotarget. 2019 Nov 12;10(61):6577-6588

Discoidin domain receptors: A promising target in melanoma.

Reger de Moura C, Battistella M, Sohail A, Caudron A, Feugeas JP, Podgorniak MP, Pages C, Mazouz Dorval S, Marco O, Menashi S, Fridman R, Lebbé C, Mourah S, Jouenne F

Pigment Cell Melanoma Res. 2019 09;32(5):697-707

A Constitutional Activating Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases.

El Bouchtaoui M, Do Cruzeiro M, Leboeuf C, Loisel-Ferreira I, Fedronie C, Ferreira C, Ait El Far R, Ziol M, Espié M, Falgarone G, Cassinat B, Kiladjian JJ, Feugeas JP, Janin A, Bousquet G

Clin. Cancer Res.. 2019 07 15;25(14):4504-4515

A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.

Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, Mourah S

Oncotarget. 2019 Mar 1;10(18):1669-1687

EMT is associated with an epigenetic signature of ECM remodeling genes.

Peixoto P, Etcheverry A, Aubry M, Missey A, Lachat C, Perrard J, Hendrick E, Delage-Mourroux R, Mosser J, Borg C, Feugeas JP, Herfs M, Boyer-Guittaut M, Hervouet E

Cell Death Dis. 2019 Feb 27;10(3):205

Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.

Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, Desgrandchamps F, Mongiat-Artus P, Feugeas JP

Am. J. Surg. Pathol.. 2018 04;42(4):423-441

Mutator genomes decay, despite sustained fitness gains, in a long-term experiment with bacteria.

Couce A, Caudwell LV, Feinauer C, Hindré T, Feugeas JP, Weigt M, Lenski RE, Schneider D, Tenaillon O

Proc. Natl. Acad. Sci. U.S.A.. 2017 Oct 24;114(43):E9026-E9035

Molecular characteristics of Angiopoietin 2-associated Colorectal Carcinoma.

Jary M, Hasanova R, Faucheu H, Borg C, Feugeas JP

Ann. Oncol.. 2017 Oct;28 Suppl 7:vii31-vii32

Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.

Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, Bertheau P, Le Rhun E, Bonneterre J, Janin A, Bousquet G

Oncotarget. 2017 Jun 6;8(23):37332-37341

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.

Bousquet G, El Bouchtaoui M, Sophie T, Leboeuf C, de Bazelaire C, Ratajczak P, Giacchetti S, de Roquancourt A, Bertheau P, Verneuil L, Feugeas JP, Espié M, Janin A

Oncotarget. 2017 May 23;8(21):35205-35221

Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.

Romero M, Gapihan G, Castro-Vega LJ, Acevedo A, Wang L, Li ZW, El Bouchtaoui M, Di Benedetto M, Ratajczak P, Feugeas JP, Thieblemont C, Saavedra C, Janin A

Oncotarget. 2017 Mar 7;8(10):16243-16258

Factors of Rapid Cognitive Decline in Late Onset Alzheimer's Disease.

Koskas P, Henry-Feugeas MC, Feugeas JP, Ou P, Drunat O

Curr Aging Sci. 2017 ;10(2):129-135

Links between Transcription, Environmental Adaptation and Gene Variability in Escherichia coli: Correlations between Gene Expression and Gene Variability Reflect Growth Efficiencies.

Feugeas JP, Tourret J, Launay A, Bouvet O, Hoede C, Denamur E, Tenaillon O

Mol. Biol. Evol.. 2016 10;33(10):2515-29

EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S

Exp. Dermatol.. 2016 08;25(8):618-22